Parathyroid hyperplasia, adenomas, and carcinomas

Differential expression of p27(Kip1) protein

Lori A. Erickson, Long Jin, Peter Wollan, Geoffrey B. Thompson, Jon A. Van Heerden, Ricardo V. Lloyd

Research output: Contribution to journalArticle

93 Citations (Scopus)

Abstract

The histologic spectrum of proliferative parathyroid lesions (hyperplasia, adenoma, and carcinoma) often overlap, and differentiation between these lesions may at times be difficult. p27(kip1) (p27) is a cyclin- dependent kinase inhibitor that helps regulate the transition from the G1 to the S phase of the cell cycle. Significantly higher levels of p27 expression have been detected in some normal tissues than in their neoplastic counterparts. The authors analyzed a series of parathyroid lesions to determine if expression of this cell cycle protein may be useful in distinguishing between parathyroid hyperplasia, adenomas, and carcinomas. Formalin-fixed paraffin-embedded tissues from randomly selected patients (22 histologically normal parathyroid glands, 33 cases of hyperplasia, 43 adenomas, and 17 carcinomas) were analyzed for expression of p27 by immunostaining. All cases were also immunostained for Ki67 with antibody MIB- 1. The distribution of immunoreactivity was analyzed by quantifying the percentage of positive nuclei that was expressed as the labeling index (LI). In situ hybridization (ISH) for p27 mRNA was done using a cRNA probe with 30 of these cases. Normal parathyroid glands had the highest p27 LI (89.6 ± 1.4), followed by hyperplasia (69.6 ± 7.5), adenomas (56.8 ± 3.4), and carcinomas (13.9 ± 2.6). ISH showed no differences in p27 mRNA, indicating that the expression of the p27 gene was controlled at a posttranslational level in parathyroid tissues. Ki67 expression was significantly higher in carcinomas (LI = 8.4 ± 1.9) than in adenomas (LI = 2.7 ± 0.2) and hyperplasia (LI = 3.3 ± 0.4). These results suggest that both p27 and Ki67 may be helpful in the diagnosis of histologically difficult parathyroid lesions.

Original languageEnglish (US)
Pages (from-to)288-295
Number of pages8
JournalAmerican Journal of Surgical Pathology
Volume23
Issue number3
DOIs
StatePublished - Mar 1999

Fingerprint

Cyclin-Dependent Kinase Inhibitor p27
Parathyroid Neoplasms
Hyperplasia
Adenoma
Carcinoma
Parathyroid Glands
In Situ Hybridization
Complementary RNA
Cell Cycle Proteins
Messenger RNA
Cyclin-Dependent Kinases
S Phase
Paraffin
Formaldehyde
Cell Cycle
Gene Expression

Keywords

  • Cell cycle
  • Ki67
  • MIB1
  • p27
  • Parathyroid

ASJC Scopus subject areas

  • Anatomy
  • Pathology and Forensic Medicine

Cite this

Parathyroid hyperplasia, adenomas, and carcinomas : Differential expression of p27(Kip1) protein. / Erickson, Lori A.; Jin, Long; Wollan, Peter; Thompson, Geoffrey B.; Van Heerden, Jon A.; Lloyd, Ricardo V.

In: American Journal of Surgical Pathology, Vol. 23, No. 3, 03.1999, p. 288-295.

Research output: Contribution to journalArticle

Erickson, Lori A. ; Jin, Long ; Wollan, Peter ; Thompson, Geoffrey B. ; Van Heerden, Jon A. ; Lloyd, Ricardo V. / Parathyroid hyperplasia, adenomas, and carcinomas : Differential expression of p27(Kip1) protein. In: American Journal of Surgical Pathology. 1999 ; Vol. 23, No. 3. pp. 288-295.
@article{950d1056593642bba63b874c9c9276e6,
title = "Parathyroid hyperplasia, adenomas, and carcinomas: Differential expression of p27(Kip1) protein",
abstract = "The histologic spectrum of proliferative parathyroid lesions (hyperplasia, adenoma, and carcinoma) often overlap, and differentiation between these lesions may at times be difficult. p27(kip1) (p27) is a cyclin- dependent kinase inhibitor that helps regulate the transition from the G1 to the S phase of the cell cycle. Significantly higher levels of p27 expression have been detected in some normal tissues than in their neoplastic counterparts. The authors analyzed a series of parathyroid lesions to determine if expression of this cell cycle protein may be useful in distinguishing between parathyroid hyperplasia, adenomas, and carcinomas. Formalin-fixed paraffin-embedded tissues from randomly selected patients (22 histologically normal parathyroid glands, 33 cases of hyperplasia, 43 adenomas, and 17 carcinomas) were analyzed for expression of p27 by immunostaining. All cases were also immunostained for Ki67 with antibody MIB- 1. The distribution of immunoreactivity was analyzed by quantifying the percentage of positive nuclei that was expressed as the labeling index (LI). In situ hybridization (ISH) for p27 mRNA was done using a cRNA probe with 30 of these cases. Normal parathyroid glands had the highest p27 LI (89.6 ± 1.4), followed by hyperplasia (69.6 ± 7.5), adenomas (56.8 ± 3.4), and carcinomas (13.9 ± 2.6). ISH showed no differences in p27 mRNA, indicating that the expression of the p27 gene was controlled at a posttranslational level in parathyroid tissues. Ki67 expression was significantly higher in carcinomas (LI = 8.4 ± 1.9) than in adenomas (LI = 2.7 ± 0.2) and hyperplasia (LI = 3.3 ± 0.4). These results suggest that both p27 and Ki67 may be helpful in the diagnosis of histologically difficult parathyroid lesions.",
keywords = "Cell cycle, Ki67, MIB1, p27, Parathyroid",
author = "Erickson, {Lori A.} and Long Jin and Peter Wollan and Thompson, {Geoffrey B.} and {Van Heerden}, {Jon A.} and Lloyd, {Ricardo V.}",
year = "1999",
month = "3",
doi = "10.1097/00000478-199903000-00007",
language = "English (US)",
volume = "23",
pages = "288--295",
journal = "American Journal of Surgical Pathology",
issn = "0147-5185",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Parathyroid hyperplasia, adenomas, and carcinomas

T2 - Differential expression of p27(Kip1) protein

AU - Erickson, Lori A.

AU - Jin, Long

AU - Wollan, Peter

AU - Thompson, Geoffrey B.

AU - Van Heerden, Jon A.

AU - Lloyd, Ricardo V.

PY - 1999/3

Y1 - 1999/3

N2 - The histologic spectrum of proliferative parathyroid lesions (hyperplasia, adenoma, and carcinoma) often overlap, and differentiation between these lesions may at times be difficult. p27(kip1) (p27) is a cyclin- dependent kinase inhibitor that helps regulate the transition from the G1 to the S phase of the cell cycle. Significantly higher levels of p27 expression have been detected in some normal tissues than in their neoplastic counterparts. The authors analyzed a series of parathyroid lesions to determine if expression of this cell cycle protein may be useful in distinguishing between parathyroid hyperplasia, adenomas, and carcinomas. Formalin-fixed paraffin-embedded tissues from randomly selected patients (22 histologically normal parathyroid glands, 33 cases of hyperplasia, 43 adenomas, and 17 carcinomas) were analyzed for expression of p27 by immunostaining. All cases were also immunostained for Ki67 with antibody MIB- 1. The distribution of immunoreactivity was analyzed by quantifying the percentage of positive nuclei that was expressed as the labeling index (LI). In situ hybridization (ISH) for p27 mRNA was done using a cRNA probe with 30 of these cases. Normal parathyroid glands had the highest p27 LI (89.6 ± 1.4), followed by hyperplasia (69.6 ± 7.5), adenomas (56.8 ± 3.4), and carcinomas (13.9 ± 2.6). ISH showed no differences in p27 mRNA, indicating that the expression of the p27 gene was controlled at a posttranslational level in parathyroid tissues. Ki67 expression was significantly higher in carcinomas (LI = 8.4 ± 1.9) than in adenomas (LI = 2.7 ± 0.2) and hyperplasia (LI = 3.3 ± 0.4). These results suggest that both p27 and Ki67 may be helpful in the diagnosis of histologically difficult parathyroid lesions.

AB - The histologic spectrum of proliferative parathyroid lesions (hyperplasia, adenoma, and carcinoma) often overlap, and differentiation between these lesions may at times be difficult. p27(kip1) (p27) is a cyclin- dependent kinase inhibitor that helps regulate the transition from the G1 to the S phase of the cell cycle. Significantly higher levels of p27 expression have been detected in some normal tissues than in their neoplastic counterparts. The authors analyzed a series of parathyroid lesions to determine if expression of this cell cycle protein may be useful in distinguishing between parathyroid hyperplasia, adenomas, and carcinomas. Formalin-fixed paraffin-embedded tissues from randomly selected patients (22 histologically normal parathyroid glands, 33 cases of hyperplasia, 43 adenomas, and 17 carcinomas) were analyzed for expression of p27 by immunostaining. All cases were also immunostained for Ki67 with antibody MIB- 1. The distribution of immunoreactivity was analyzed by quantifying the percentage of positive nuclei that was expressed as the labeling index (LI). In situ hybridization (ISH) for p27 mRNA was done using a cRNA probe with 30 of these cases. Normal parathyroid glands had the highest p27 LI (89.6 ± 1.4), followed by hyperplasia (69.6 ± 7.5), adenomas (56.8 ± 3.4), and carcinomas (13.9 ± 2.6). ISH showed no differences in p27 mRNA, indicating that the expression of the p27 gene was controlled at a posttranslational level in parathyroid tissues. Ki67 expression was significantly higher in carcinomas (LI = 8.4 ± 1.9) than in adenomas (LI = 2.7 ± 0.2) and hyperplasia (LI = 3.3 ± 0.4). These results suggest that both p27 and Ki67 may be helpful in the diagnosis of histologically difficult parathyroid lesions.

KW - Cell cycle

KW - Ki67

KW - MIB1

KW - p27

KW - Parathyroid

UR - http://www.scopus.com/inward/record.url?scp=0033011830&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033011830&partnerID=8YFLogxK

U2 - 10.1097/00000478-199903000-00007

DO - 10.1097/00000478-199903000-00007

M3 - Article

VL - 23

SP - 288

EP - 295

JO - American Journal of Surgical Pathology

JF - American Journal of Surgical Pathology

SN - 0147-5185

IS - 3

ER -